Suzetrigine for Pain After Total Knee Arthroplasty
This study is looking at how well Suzetrigine helps manage pain after total knee arthroplasty (TKA), also known as total knee replacement surgery. Researchers want to see if taking Suzetrigine can reduce the need for opioid pain medications after surgery. You might be able to join if you are between 18 and 80 years old, have a body mass index (BMI) between 18 and 40, and are scheduled for your first total knee replacement on one knee. The main goal is to see how many participants can stay opioid-free for up to 14 days after surgery. The study is currently recruiting about 60 participants, but its overall status is unclear.
- Study design
- This is an interventional study involving about 60 participants. Participants will receive either Suzetrigine tablets or a matching placebo.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured from Day 1 up to Day 14 after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of Pain Treatment After Total Knee Arthroplasty
At a glance
Conditions
Where it's being run
2 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Total Opioid Usage24 hours to 168 hours after the first dose of study drug